Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
Neurology|April 13, 2005
An open label study of the effects of rituximab in neuromyelitis opticaB A C Cree, S Lamb, K Morgan, et al.Neurology|May 10, 2000
Magnetization transfer ratio in new MS lesions before and during therapy with IFNbeta-1aM Kita, D E Goodkin, P Bacchetti, et al.Neurology|January 15, 2003
IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMSE Waubant, D Goodkin, A Bostrom, et al.Neurology|August 26, 2011
Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of childrenA Langer-Gould, J L Zhang, J Chung, et al.Journal of Neuroimmunology|December 8, 2000
Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MSE Waubant, L Gee, P Bacchetti, et al.European Journal of Neurology|November 1, 2015
Vitamin D in clinically isolated syndrome: evidence for possible neuroprotectionE M Mowry, D Pelletier, Z Gao, et al.Neurology|April 18, 2007
Treatment of pediatric multiple sclerosis and variantsD Pohl, E Waubant, B Banwell, et al.Neurology|October 1, 2008
Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype?D Chabas, T Castillo-Trivino, E M Mowry, et al.Revue Neurologique|April 1, 1996
[Ischemic cerebrovascular complications in Rendu-Osler disease: a case]J F Albucher, P Carles, J Giron, et al.Neurology|July 23, 2003
Clinical characteristics of responders to interferon therapy for relapsing MSE Waubant, S Vukusic, L Gignoux, et al.Pageof 6